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Abbreviations 
AGDs — Anogenital distances  
AGDac — Ano-clitoral distance from the centre of the anus to the anterior base of the clitoris  
AGDaf — Ano-fourchettal distance from the centre of the anus to the fourchette  
AGDap — Ano-penile distance from the centre of the anus to the anterior base of the penis  
AGDas — Ano-scrotal distance from the centre of the anus to the posterior base of the 
scrotum 
AGDlower  — measured from the centre of the anus to the base of the labio/scrotal border 
AGDupper  — measured from the centre of the anus to the anterior base of the genital 
tubercle 
AGDl/u  —  lower / upper AGD ratio 
COST — European Cooperation in Science and Technology  
EGS — External Genitalia Score   
PS — Prader Score 
EMS — External Masculinization Score 
DSDs — Differences of sex development  
ICC — Interclass correlation coefficient  
CI — confidence interval 
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Abstract  
Context: Standardized description of external genitalia is needed in the assessment of 
children with atypical genitalia.  
Objectives: To validate the External Genitalia Score (EGS), to present reference values for 
preterm and term babies up to 24 months and correlate obtained scores with anogenital 
distances (AGDs).  
Design, Setting: A European multicentre (n=8) validation study  was conducted from 
07/2016 until 07/2018.  
Patients and Methods 
EGS is based on the external masculinization score but uses a gradual scale from female to 
male (range 0-12) and terminology appropriate for both sexes. The reliability of EGS and 
AGD’s were determined by the interclass correlation coefficient (ICC). Cross-sectional data 
were obtained in 686 term (0-24 months), and 181 preterm babies and 111 babies with 
atypical genitalia. 
Results: ICC of EGS in typical and atypical genitalia is excellent and good. Median EGS 
(10
th 
-
 
90
th 
centile) in males < 28 weeks gestation is 10 (8.6-11.5); in males 28-32 weeks 11.5 
(9.2-12); in males 33-36 weeks 11.5 (10.5-12) and in full-term males 12 (10.5-12). In all 
female babies, EGS is 0 (0-0). The mean (SD) AGDl/u is 0.45 (0.1), with significant 
difference between AGDl/u in males 0.49 (0.1) and females 0.39 (0.1) and in-between values 
in DSD 0.43 (0.1). AGDl/u correlates with EGS in males with typical genitalia and in  
atypical genitalia.  
Conclusions: EGS is a reliable and valid tool to describe external genitalia in premature and 
term babies up to 24 months. EGS correlates with AGDl/u in males. It facilitates standardized 
assessment, clinical decision-making and multicenter research. 
Précis 
The EGS is a new instrument to describe external genitalia, enabling comprehensive 
assessment of atypical genitalia. The EGS was validated and reference values for preterm and 
term babies up to 24 months are presented.  
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Introduction 
Differences (or disorders) of sex development (DSDs) are heterogeneous congenital 
conditions that affect the development of the urogenital tract and reproductive system and 
result in atypical sex differentiation. 
1-4
 The incidence of DSDs where sex assignment may be 
unclear at birth is estimated at 1/5500 births. 
5
 For milder variations such as hypospadias, 
prevalence rates vary from 13.8 to 40/10.000. 
6-7
 The clinical management of these conditions 
is complex and requires specialised care by a multidisciplinary team. 
1,8
 A precise 
understanding of the underlying cause, preferably up to the molecular genetic level, is crucial 
to allow individualized management as well as for research purposes. Detailed evaluation of 
the genital phenotype will inform clinicians about the need for further referral to an expert 
center, and guide them to specific diagnostic tests such as hormonal, imaging and genetic 
investigations. 
9
 The genital phenotype at birth has also been related to long-term outcomes, 
e.g. with regard to genital (dis)satisfaction 
10
, the prevalence of cardiac 
11
 or other co-
morbidities 
12
 or risk for the development of gonadal germ cell tumors. 
13,14
  The relevance of 
a precise description of the genital phenotype has even increased in recent years as genital 
surgery in childhood has become controversial, and many children who have a DSD 
nowadays grow up with a genital difference. The long-term outcome of this approach will 
need to be determined. Lastly, given that the individual DSD conditions are (very) rare, 
meaningful research requires a multicenter approach and thus a standardized battery of tools 
across centers to assess and document this phenotypic variability.  
A comprehensive genital exam contains the following landmarks: the presence and location of 
the gonads, genital tubercle development, degree of fusion of the labio-scrotal folds and 
location of the urethral meatus. A micropenis is defined as a short penis, ≤ 24-25 mm, i.e. ≤ 
2.5 SD below the mean and with a normal configuration. 
15
 Minor racial differences for SPL 
have been published. 
16
 The distance between the anus and various landmarks of the external 
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genitalia has been shown to be a sensitive index of androgen activity during fetal development 
and is sexually dimorphic. 
17,18
 Various anogenital distances (AGDs) have been proposed.   In 
male term newborns, the mean (SD) anoscrotal anogenital distance (AGDas), measured from 
the centre of the anus to the posterior scrotal wall is 24.7 (4.5) mm. In female term newborns 
the mean (SD) anofourchette AGD (AGDaf), measured from the centre of the anus to the 
fourchette is 16.0 (3.2) mm. 
17
 AGDas and AGDaf are represented in Figure 1 as lower AGD 
(AGDl); anopenile AGD (AGDap) and anoclitoral AGD (AGDac) are represented as upper 
AGD (AGDu). A shorter AGDas and penile length have been found in infants with 
hypospadias and cryptorchidism, a longer AGDaf has been described in female infants with 
androgen excess, e.g. in congenital adrenal hyperplasia (CAH). In typical female infants, it 
was shown that calculating the anogenital-ratio (AGDaf/ac) offers advantages as it follows a 
normal distribution and does not correlate with anthropometric variables or gestational age. 
19,20
 
 
The Prader score (PS) was developed by Andrea Prader in 1954 to capture genital 
variation in children who have CAH. Apart from the typical female and male phenotypes, it 
categorizes external genitalia in children with CAH in 5 additional stages with progressive 
virilization from a phenotypic female with mild clitoromegaly (stage 1) to a phenotypic male 
with glandular hypospadias (stage 5). 
21
 In 2000, the External Masculinization Score (EMS)  
was introduced to improve the initial assessment of boys with a genital difference. The EMS 
(range 0-12) allocates points to five different characteristics of the external genitalia (scrotal 
fusion 3/0, micropenis < 25 mm 3/0, urethral meatus 3/2/1/0, right and left gonad 1,5/1/0). 
22
  
The EMS allows standardization of genital assessment, but a refinement of the score is 
needed to capture the appearance of the genitalia more comprehensively across the 
phenotypic spectrum in both sexes. We here present the External Genitalia Score (EGS) 
(Table 1 and supplemental Table 1 
23
) as a modified, non-binary version of EMS. EGS was 
developed by Working Group 1 of the European Cooperation in Science and Technology 
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(COST) Action BM1303. The EGS uses a gradual scale from female to male (range 0-12) of 
the same anatomical landmarks as the EMS. To provide a full description of the external 
genitalia, the various AGDs were measured and, in line with EGS, a gender-neutral lower / 
upper AGD ratio (AGDl/u) was calculated as a marker of genital virilisation independent of 
body weight (Figure 1).   
Materials and Methods  
Based on expert opinion and group discussions, members of the DSDnet COST Action 
(www.dsdnet.eu) working group 1 modified the existing  EMS  to describe the same 
anatomical features with a  refined categorical scale for the items labio/scrotal fusion, urethral 
meatus and the position of the gonads and a continuous scale for the size of the genital 
tubercle, ranging  from typical female to typical male (Table 1 and supplemental Table 1 
23
). 
In addition, the vocabulary was adjusted in a way that suits both sexes. 
Measurements 
Genital assessment and measurements included EMS and EGS , PS, and AGD’s. The same 
digital caliper (Carbon Fiber Digital Caliper, resolution: 0.1 mm, QST-Express, type QST008, 
China) was used for all measurements across centers. Length of the genital tubercle (GTL) 
was measured along its dorsal aspect in a non-erect state, gently stretching it between two 
fingers until the point of increased resistance, from the base of the genital tubercle (as close to 
the pubic bone as possible) to the tip of the glans and excluding the foreskin. 
15
  The 
measurement was performed twice, and the mean was calculated. Location of the gonads was 
determined by palpation, as described by Ogilvy-Stuart. 
3
 The position of the meatus and 
degree of labio-scrotal fusion were determined by visual inspection. AGD measurements were 
standardized according to the Infant Development and the Environment Study (TIDES)
17
, 
with some modifications, and the accompanying training video (kindly provided by the 
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TIDES research group) was distributed among participating centers. Modifications to TIDES 
method: The baby is placed in the middle of the bed instead of at the edge to allow the same 
position in premature babies in the incubator. For the same reason, the fixed end of the caliper 
is held at the centre of the anus, and the sliding part of the caliper is  moved while measuring 
the AGD’s. The sliding part is touching but not compressing the skin at the anterior base of 
the genital tubercle to standardize measurements in male and female infants. The examiner 
does not use a marker for the mid-anus position but chooses a wrinkle in the centre of the 
anus to use for the measurement of the two AGD’s. The average of two measurements is used 
for analysis instead of the average of three measurements.  AGDl was measured from the 
centre of the anus to the base of the labio/scrotal border and AGDu was measured from the 
centre of the anus to the anterior base of the genital tubercle. PS was determined by visual 
inspection and EMS, EGS and AGDl/u were calculated based on the obtained scores and 
AGD measurements.  
Participants 
First, the inter-observer reliability of PS, EMS, EGS and inter- and intra-observer reliability 
of AGDl/u were determined by two observers from two different centers in 35 babies with 
typical genitalia (12 female, 23 male; 12 preterm, 23 term). Subsequently, the reliability of 
these parameters was assessed by two observers in four different centers in 66 babies with 
atypical genitalia (males with “mild non-specific undermasculinization”; i.e. isolated 
hypospadias (n=29) or isolated cryptorchidism (n=8)”, 46, XY DSD (n=22), Sex 
Chromosome DSD (n=2) and 46,XX DSD (n=5) (Supplemental Table 2) 
23
. 
A collaborative multicenter study was then conducted in eight European clinical centers from 
July 2016 until July 2018, to establish reference data for the EGS in typical genitalia (Table 2 
). For this purpose, the external genitalia of preterm infants, term infants up to 1 month and 
babies from 1 to 24 months were assessed by one observer per center and PS, EMS, EGS, 
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GTL and AGDl/u  were determined. The following potential covariates were noted: maternal 
age, ethnicity, virilization and medication use in pregnancy, exposure to toxic products, 
smoking in pregnancy, history of consanguinity, gestational age at birth, weight and length at 
birth, weight and length at assessment. Children with a major congenital malformation 
(central, cardiac, pneumologic, urologic) were excluded. In total, 105 male and 76 female 
preterm (< 37 weeks) neonates, 178 male and 200 female term neonates, and 153 male and 
155 female babies aged 1-24 months were assessed. In four clinical centers the PS, EMS, 
EGS and AGD l/u were obtained in babies with atypical genitalia (see Supplemental Table  3 
for participant characteristics 
23
). 
Statistical analyses  
The inter-observer reliability of the PS, EMS and EGS and the intra- and inter-observer 
reliability for AGDs were assessed by Intraclass Correlation Coefficient (ICC) estimates and 
their 95% confidence intervals (CI), based on absolute-agreement, 2-way random-effect 
model. 
24
  The median (10
th 
–
 
90
th
centile) for EGS and EMS were generated. Spearman’s rho 
determined the correlation between EGS and EMS as both have a skewed distribution. The  
Bland–Altman analysis was used to assess agreement between the EGS and EMS. This 
method calculates the mean difference between two methods, and 95% limits (2 SD) of 
agreement of the differences between the two methods. 
25
 The mean (SD, 10
th 
–
 
90
th
centile) 
for the different AGDs and AGD-ratios was calculated in typical and in atypical genitalia. 
Correlations of the different AGDs and the AGDl/u  with weight, length and age were 
assessed by Pearson analysis. Potential covariates of the different AGDs and AGDl/u were 
assessed by linear regression. A Spearman's correlation was done to determine the 
relationship between EGS and AGDl/u. An independent-samples t-test was conducted to 
compare AGDl/u in typical and atypical genitalia. All analyses were performed using the 
SPSS statistical package version 25. 
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Ethics 
The study was approved by the local ethical committees of each participating center (Local 
IDs: Ghent: B670201628499, Medical University of Vienna 1872/2014), Rotterdam: MEC-
2016-706, Copenhagen: H-15014876 and RH-2015-210-04146, Katowice: 
KNW/0022/KB1/158/I/16/17/18, Stockholm Karolinska University Hospital 2008/167-31/3, 
2009-01-13, 10-12-16. Messina: MEC 104/16. Informed consent was obtained from at least 
one parent or legal guardian for each child.    
Results 
Inter-observer reliability of EGS in comparison with EMS, PS and of the various AGDs 
As the EGS is a more refined modification of the EMS, we compared its reliability to the 
original EMS, and to the PS, which is historically the most widely used. Inter-observer ICC 
(n=35) for EGS showed no case of disagreement between any scorer (excellent) in typical 
genitalia (ICC=1) and, the interobserver variability in atypical genitalia (n=66)  was good 
(ICC=0.89, CI 0.82-0.93). Likewise, inter-observer ICC for PS and EMS  also showed no 
case of disagreement  in typical and were moderate and good in atypical genitalia. Inter-
observer ICC for the different AGDs and genital tubercle length were moderate for AGDu  
and good for AGDl and genital tubercle length in typical male genitalia and good for AGDu, 
AGDl and genital tubercle length in atypical genitalia. Inter-observer ICC were good for 
AGDl and, AGDu in typical female genitalia. Intra-observer ICC for the different AGDs and 
genital tubercle length were good or excellent in both typical and atypical genitalia 
(Supplemental Table 2) 
23
. 
Reference data for genital tubercle length,  EGS, AGDs and AGDl/u  
As a new measuring instrument, we established reference data for EGS, including data in pre- 
and dysmature babies who present more often with atypical genitalia.
12
  In addition, we 
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determined AGDs and AGDl/u to investigate correlations of  EGS with other measures of 
genital virilisation. In male term infants with typical genitalia, the mean (SD) genital tubercle 
length (n=174), AGDl and AGDu (n=178) were 31.2 (5.4), 24.6 (4.7) and 47.6 (5.8) mm 
respectively. In female term infants with typical genitalia (n=200), the mean (SD) length of 
AGDl and AGDu were 14.8 (3.5) and 37.8 (4.5) mm respectively. AGDl/u was independent 
of  body weight (Figure 2). Although  mean (SD) AGDl/u  in male infants [0.49 (0.1)], 
significantly differs from AGDl/u in female infants [0.39 (0.1)], large overlap exists between 
both groups (Table 3, Figure 2). AGD l/u  in male neonate positively correlates with 
gestational age (r(243) = 0.3, p<0.05).  No univariate or bivariate correlation was detected 
between AGD l/u  and any of the other covariates (maternal age, ethnicity, center, virilization 
and/or medications used in pregnancy, exposure to toxic products or smoking during 
pregnancy). In typical male infants, the median and 10
th 
centile EGS gradually rise with 
increasing gestational age and birth weight due to increasing genital tubercle length and 
descent of the testes (Figure 3A and 3B). In addition, the EGS 10
th
 centile gradually increases 
with age up to 24 months. Median EGS in typical female premature and full-term babies up to 
24 months is 0 (0-0) (Table 2). 
Genital tubercle length,  EGS, AGDs and AGDl/u in children with atypical external 
genitalia 
In babies with atypical genitalia, the EGS covers the whole phenotypic spectrum, resulting in 
scores ranging from 0 to 12 with large overlap between the various DSD categories (46,XX 
DSD, 46,XY DSD and 45,X/46,XY DSD) (Table 4 and Figure 3C). In male babies with 
atypical genitalia (46,XY DSD and “mild non-specific  undermasculinization”), AGDl/u 
(M=0.43, SD=0.11) is significantly shorter than AGDl/u in typical males  (M=0.49, 
SD=0.09); t(95.1) = 4.8, p<0.05), however AGDl/u widely varies in babies with atypical 
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genitalia, with a mean 0.43 (0.1 SD) not different from mean AGDl/u 0.45 (0.1) in babies 
with typical genitalia (Figure 2). 
Correlation and agreement between scores and measures 
AGDl, AGDu and AGDl/u positively correlate with EGS in typical male full term neonates as 
well as in babies with atypical genital phenotypes (rs (243)= 0.19, p < 0.05 and rs (78) = 0.35, 
p <0.05 respectively) (Supplemental Table 4) 
23
. As expected, there is a strong, positive 
correlation between EGS and EMS in typical (rs (853) = 0.97, p < 0.05) and atypical genitalia 
(rs (110) = 0.9, p < 0.05) (Supplemental Figure 1A) 
23
. The Bland-Altman analysis shows that 
optimal agreement between the two methods is reached for EMS/EGS results < 3 and > 9.5 
(Supplemental Figure 1B) 
23
.  
Discussion 
The EMS, developed by Ahmed et al. in 2000 
22
 provides an objective and standardized tool 
to describe external genitalia in male babies and has been correlated with various DSD-related 
outcomes. 
10-14 
A major limitation of the EMS in the work-up of an infant with atypical 
genitalia is that it cannot be applied in assigned females because of the gender-specific design 
and vocabulary (e.g. micropenis yes/no, scrotal fusion yes/no). Also, EMS does not capture 
the full phenotypic spectrum of genital variation that characterises DSD conditions due to its 
dichotomous nature. To overcome these problems, COST Action BM1303 working group 1 
modified the EMS in a gender-neutral and more  refined categorical scale, that better reflects 
the naturally occurring variation (e.g. by introducing the option “posterior labioscrotal 
fusion”). The resulting tool was termed the EGS and was subsequently validated  in a large 
European multicenter study. EGS can be applied in both typical male and female babies and 
in babies who have variations in their genital characteristics. We provide normative data for 
premature, low birth weight and full-term babies until the age of two years for a mixed 
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European population. Such data are of particular relevance given the frequent association in 
males of intra-uterine growth retardation with genital undermasculinization and the 
difficulties in assessing genital variation in preterm infants whose testes have not yet 
descended and whose penis has not yet reached its full-term length. Although the EGS can be 
used for the initial evaluation of babies with atypical genitalia, it cannot fully replace a more 
detailed qualitative genital description. The EGS does not inform on the presence of other 
atypical genital features such as complete or partial penoscrotal transposition, scrotal 
anomalies or degree of penile curvature. Moreover, EGS, like EMS, does not provide 
information on important internal genital characteristics in the context of DSD, such as the 
presence of a urogenital sinus or the location of the vaginal confluence in 46,XX babies who 
have CAH. Bland-Altman analysis reveals that EGS and EMS have least agreement in the 
group of children with atypical genitalia, i.e. children who have an EGS between 3 and 9.5. In 
our data of 66 children with a DSD, the IQRs are smaller for EGS as compared to EMS, 
support our hypothesis that the EGS allows a more refined description of genital virilisation. 
In addition, EGS is easy to use, helps to assess important landmarks of the external genitalia, 
also by physicians who do not examine a baby with variant genital development on a regular 
basis and, it is an attractive alternative for genital photography, which has ethical constraints. 
Due to its objectivity and simple design, it is also very instrumental for the exchange of data 
on genital phenotypes between centers and researchers, for example through large-scale 
registries such as I-DSD. Future research and clinical use of EGS will reveal if specific EGS 
outcomes can be allocated to specific diagnoses/mutated genes, but based on our preliminary 
data, it is expected that EGS will have little predictive value regarding the underlying 
diagnosis in most cases, given the large overlap between the various DSD categories. 
Reference data for the EGS in term, preterm and low birthweight children, are of high 
relevance for a broad audience of paediatricians and general practitioners. According to 
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Ahmed et al 
9
, clinical evaluation by a specialized DSD-team is advised in proximal forms of 
hypospadias, isolated micropenis, isolated clitoromegaly, any form of familial hypospadias, 
and those who have a combination of genital variations resulting in an EMS of less than 11. 
All these variations will result in a maximal EGS of 10.5, corresponding to P10 in full-term 
male infants. Therefore, based on our data, we advise referral to a specialised DSD team of 
any full-term infant who has an EGS > 0 and  ≤ 10.5 (or ≤ P10), and of any preterm or low 
birthweight infant who has an EGS > 0 and  ≤  P10 for gestational age or birthweight, 
independent of maternal age, ethnicity, virilization and/or medications used in pregnancy, 
exposure to toxic products or maternal smoking. Of note, the obtained EGS will not lead to a 
specific diagnosis in an infant who has variant genitalia, but it may justify further genetic, 
biochemical and hormonal diagnostic investigations. Further research is mandatory to 
determine if this recommendation will require adjustments in the future.   
The anogenital distance has been shown a surrogate marker of prenatal androgen exposure 
and has been correlated to various endocrine-reproductive outcomes. 
26-28
 Although it adds to 
the description of the external genitalia 
29
, its clinical use is limited as it is relatively time-
consuming and measurements are hard to standardize among different observers. As AGD is 
known to correlate with anthropometric variables, which was confirmed in our study, the 
AGD-ratio may represent a more useful marker. In our study, AGDl/u followed a normal 
distribution and did not correlate with any of the anthropometric variables. Moreover, while 
mean GDl/u significantly differs between typical males and typical females, this measure 
underscores the naturally encountered variation in genital phenotypes, both in typical males 
and females and in children who have a DSD, as becomes obvious from Figure 2. As 
expected, AGDl/u correlates with EGS in undermasculinized infants, both measurements 
independently reflecting the degree of prenatal androgen exposure.  
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A major strength of our study is its multicenter design, allowing data collection in a large 
European sample in a relatively short period. At the same time, this multicenter approach may 
constitute a weakness as some measurements, such as AGD and genital tubercle length are 
prone to larger inter-observer variability. This was also confirmed by the variable ICC scores 
obtained for these measures in our study and this may explain the relatively large SD obtained 
for these parameters. In addition the assessment of children with atypical genitalia was 
performed in 4 out of 8 centers, which could have led to recruitment bias.    
In conclusion the EGS is a reliable and easy-to-use tool that allows objective and detailed 
description of typical and variant external genitalia in neonates and infants. This facilitates 
clinical management and data exchange across centers, to study outcomes or draw genotype-
phenotype correlations. We here provide European reference data for term and premature 
neonates, for neonates who have low birthweight and for toddlers up to 24 months.  
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Figure 1. Measurement of Anogenital distances. In order to obtain a single measure that is 
suitable for all babies, AGDap and AGDac were defined as AGDu, and AGDas and AGDaf 
as AGDl.  
Abbreviations:, AGDl (AGDlower): measured from the centre of the anus  to the base of the labio/scrotal border, 
AGDu (AGDupper): measured from the centre of the anus  to the anterior base of the genital tubercle 
Figure 2. Correlation between AGDl/u and weight in babies with typical genitalia and 
atypical genitalia 
Abbreviations: ratio AGDl/u: lower/upper AGD ratio, AGDl: measured  from the centre of the anus to the base 
of the labio/scrotal border, AGDu: measured from the centre of the anus to the anterior base of the genital 
tubercle 
Figure 3. Boxplot with median and interquartile range of EGS (dark grey) in comparison with 
EMS (light grey). A: Results for  typical male babies according to gestational age.  
B: Results  for typical male babies according to birthweight. C. Results for babies with 
atypical genitalia and various DSD groups. 
Abbreviations: Mild non specific undermasculinization: refers to isolated hypospadias or isolated cryptorchidism 
Table 1. “External Genitalia Score” describe phenotypic features at 5 anatomical landmarks 
of the genitalia: degree of labioscrotal fusion, length of the genital tubercle, position of the 
urethral meatus, and location of the right and left gonad. The final score is the sum of points 
allocated to feature 1-5. 
Abbreviations: EGS: External Genitalia Score. GTL: genital tubercle length 
Table 2. EGS in female and male babies with typical genital phenotypes in different 
gestational age, birthweight and age groups 
Abbreviations: EGS: External Genitalia Score 
Table 3. Genital tubercle length, AGDs and AGDl/u in male (light grey) and female (dark 
grey) babies with a typical genital phenotype.  
Abbreviations: AGD: anogenital distance, AGDl/u: lower/upper AGD ratio, AGDu (AGDupper): measured  
from the centre of the anus to the anterior base of the genital tubercle, and AGDl (AGDlower): measured from 
the centre of the anus to the base of the labio/scrotal border.  
Table 4. EGS median,10
th 
-
 
90
th 
centile scores and AGDl/u in babies with atypical genital 
phenotypes 
Abbreviations:AGDu: measured  from the centre of the anus to the anterior base of the genital tubercle, and 
AGDl: measured from the centre of the anus to the base of the labio/scrotal border. AGDl/u: lower/upper AGD 
ratio EGS: External  Genitalia Score, * mild non-specific undermasculinization refers to males  with isolated 
cryptorchidism or isolated hypospadias 
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgz142/5609091 by U
niversitaetsbibliothek Bern user on 03 January 2020
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgz142/5609091 by U
niversitaetsbibliothek Bern user on 03 January 2020
weight (g)
12500100007500500025000
 A
G
D
l/u
,80
,60
,40
,20
atypical genital phenotype
male
female
Page 1
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgz142/5609091 by U
niversitaetsbibliothek Bern user on 03 January 2020
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgz142/5609091 by U
niversitaetsbibliothek Bern user on 03 January 2020
